Phenolic Compounds of Therapeutic Interest in Neuroprotection
Journal of Xenobiotics · 06.02.2024 · 14 (1) · 227-246
DOI: 10.3390/jox14010014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Xenobiotics, online erschienen am 06.02.2024. Verfasst von José Manuel Nájera-Maldonado und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo 39087, Mexico. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías, CONAHCYT.
Abstract (Originalsprache)
The number of elderly people is projected to double in the next 50 years worldwide, resulting in an increased prevalence of neurodegenerative diseases. Aging causes changes in brain tissue homeostasis, thus contributing to the development of neurodegenerative disorders. Current treatments are not entirely effective, so alternative treatments or adjuvant agents are being actively sought. Antioxidant properties of phenolic compounds are of particular interest for neurodegenerative diseases whose psychopathological mechanisms strongly rely on oxidative stress at the brain level. Moreover, phenolic compounds display other advantages such as the permeability of the blood–brain barrier (BBB) and the interesting molecular mechanisms that we reviewed in this work. We began by briefly outlining the physiopathology of neurodegenerative diseases to understand the mechanisms that result in irreversible brain damage, then we provided an overall classification of the phenolic compounds that would be addressed later. We reviewed in vitro and in vivo studies, as well as some clinical trials in which neuroprotective mechanisms were demonstrated in models of different neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), Parkinson’s disease (PD), ischemia, and traumatic brain injury (TBI).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo 39087, Mexico.
- CONAHCYT National Council of Humanities, Sciences and Technologies, Autonomous University of Guerrero, Chilpancingo 39087, Mexico.
- National Technological Institute of Mexico, Technological/IT Institute of Zacatepec, Zacatepec 62780, Mexico.
ORCID-Profile: José Manuel Nájera-Maldonado, Ricardo Salazar, Macdiel Acevedo-Quiroz, Eugenia Flores-Alfaro, Mónica Ramírez
Förderung
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
- CONAHCYT
Zitieren
APA
Nájera-Maldonado, J. M., Salazar, R., Alvarez-Fitz, P., Acevedo-Quiroz, M., Flores-Alfaro, E., Hernández-Sotelo, D., Espinoza-Rojo, M., & Ramírez, M. (2024). Phenolic Compounds of Therapeutic Interest in Neuroprotection. Journal of Xenobiotics, 14(1), 227-246. https://doi.org/10.3390/jox14010014
Vancouver
Nájera-Maldonado JM, Salazar R, Alvarez-Fitz P, Acevedo-Quiroz M, Flores-Alfaro E, Hernández-Sotelo D, et al. Phenolic Compounds of Therapeutic Interest in Neuroprotection. Journal of Xenobiotics. 2024;14(1):227-246. doi:10.3390/jox14010014
BibTeX
@article{NjeraMaldonado2024,
author = {Nájera-Maldonado, José Manuel and Salazar, Ricardo and Alvarez-Fitz, Patricia and Acevedo-Quiroz, Macdiel and Flores-Alfaro, Eugenia and Hernández-Sotelo, Daniel and Espinoza-Rojo, Mónica and Ramírez, Mónica},
title = {Phenolic Compounds of Therapeutic Interest in Neuroprotection},
journal = {Journal of Xenobiotics},
year = {2024},
volume = {14},
number = {1},
pages = {227--246},
doi = {10.3390/jox14010014}
}
EUVIMED